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Introduction
We started the first Japanese trial of screening for abdom-
inal aortic aneurysm (AAA) using ultrasound (US) in
1992,1 and over 10,000 residents have participated in our
screening programme during 10 years.2 We realized that
mass screening for AAA was effective in Japan, however,
simultaneous screening of multiple abdominal solid
organs was considered to be more useful. So far, in mass
screening procedures, each abdominal organ is evaluated
individually. A simultaneous screening test of multiple
abdominal solid organs including aorta has not yet 
been established. A helical computed tomography (CT)
scanner was considered to be suitable for screening 
multiple organs in a limited time. In this study, we eval-
uated the possibility of a new screening procedure for
multiple abdominal solid organs using a mobile helical
CT scanner.
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Methods
Resident individuals of 40 years of age or older were can-
didates for this screening test. A total of 4,543 persons
including 2,022 males and 2,521 females participated in
this study beginning in June 2000. The mean age of partic-
ipants was 64 years (range, 40–94 years). The mean height
and weight of participants was 156 ± 24 (mean ± SD) cm
and 56 ± 10 kg, respectively. As to major risk factors, hyper-
tension was observed in 29% of participants, smoking
habits in 27%, hyperlipidaemia in 12%, diabetes mellitus in
8%, and ischaemic heart disease in 4%. The option of screen-
ing was determined by each local self-governing body, and
four regions were included in this onsite-screening pro-
gramme. Candidates who lived in these four regions received
this CT screening. A description of the procedure of this
screening test was given in writing to residents in advance
and the screening was performed after obtaining written
informed consent. Oral intake was prohibited except for
water for at least 4 hours prior to the scanning. Two mobile
helical CT systems (X-vision, Toshiba Co. Ltd., Tokyo and
Hispeed DX/iM, GE-Yokokawa Medical Systems, Tokyo,
Japan) were used (Figure 1). Scanning conditions were
fixed at 120 kV/150 mA for all participants. CT images were
acquired with 10-mm collimation and a pitch of 1:2, and
were reconstructed at 10-mm intervals. CT images were
acquired between the upper-side diaphragm and the sym-
physis pubis. The total radiation dose per examination was
2.7–6.8 mGy. Contrast medium was not used. Results were
evaluated using X-ray films in the first year (n = 1,250) and
on a computer screen during the most recent 3 years
(n = 3,293). Certificated specialists in radiology evaluated
the CT findings, and patients were referred to physicians
who specialized in the field of each organ for further
investigation and treatment when necessary. Screening
cost was approximately US$50 per person, and the total cost
of this screening programme was US$227,150.
Results
Screening was performed without any incident in all 
participants and good diagnostic images were obtained.
About 5 minutes were necessary for performing the screen-
ing test for each participant. The number of screened par-
ticipants ranged from 57 to 143 per day using a mobile CT
system. A total number of 2,105 abnormal findings were
detected in 1,594 (35%) participants (Table 1). Liver and
kidney diseases including urinary tract were most fre-
quent and represented approximately 30% of 2,105 abnor-
mal findings. Gallbladder disease including biliary tract
and adrenal gland disease comprised approximately 10%
of abnormalities. Besides frequent cystic or calcified
lesions, solid tumours were suspected in 56 lesions. Five
(9%) of them were confirmed as being malignant tumours
including pancreatic cancer in two patients, and liver,
lung and ovary cancers in one patient each, respectively
(Figures 2 and 3). Five patients with each malignant lesion
received curative operation. Small-sized AAAs, less than
40 mm in diameter, were detected in 22 patients.
Cardiomegaly and/or pericardial effusion were found in
10 patients, and heart valve diseases were uniquely found
in two of them. The majority of benign lesions had been
under the close observation of specialists in each field.
Among them, symptomatic gallbladder stone was operated
in 10 patients, functional adrenal gland in three and large
ovarian tumour in two. All the patients with small aortic
aneurysm and heart valve diseases were under follow-up.
Screening cost for a malignant and benign tumour was
US$45,430 and US$4,454, respectively. That for an
aneurysm and heart valve disease was US$10,325 and
US$113,575, respectively (Table 2).
Discussion
Screening of each abdominal solid organ using US or CT
have already been reported.3 However, many such screen-
ing procedures were performed in selected high-risk per-
sons probably due to cost-effectiveness. For example,
screening for hepatocellular carcinoma have been mainly
performed in patients with chronic hepatitis, cirrhosisFigure 1. Mobile computed tomography scanner unit.
■ ISHIKAWA et al ■
120 ASIAN JOURNAL OF SURGERY VOL 30 • NO 2 • APRIL 2007
and family histories.4–6 Mihara et al7 reported efficacy of
US screening including a large number of participants, but
screened organs were limited to the liver, gallbladder, pan-
creas, and kidney. Oshibuchi et al8 reported the results of
abdominal US screening of multiple organs in 715 partici-
pants. In their study, gross abnormalities were found 
in 42% of total examinees, which was similar to our 35%;
however, abnormal findings in adrenal gland, prostate and
vascular systems were not detected. US has been commonly
used for the screening of abdominal organs because of its
portability and accuracy; however, it is a difficult job for the
examiners, even with specialized US techniques, to complete
screening of multiple abdominal organs of a large num-
ber of examinees within a limited time.
A mobile CT scanner has been used in mass screening
for lung cancer.9 Mass screening for multiple abdominal
organs using mobile CT scanner has not yet been reported.
In establishing this abdominal screening programme, we
considered a number of issues about suitable scanning
conditions, screening time and a larger load on X-ray system
Figure 2. Pancreas cyst was detected by screening computed
tomography, and finally diagnosed as invasive mucinous 
cystadenocarcinoma.
Figure 3. A consolidation was detected in the right lower lobe 
by screening computed tomography, and finally diagnosed as 
adenocarcinoma.
Table 1. Results of screening by computed tomography
Total
Number of lesions*
Major findingsOrgan
(n= 2,105)
Tumour Others
Liver 632 (30%) 9 (malignant 1) Cyst: 308; fatty liver: 218; calcification: 38; 
cirrhosis: 18
Gallbladder/biliary tract 236 (11%) 2 (benign) Stone: 196 (gallbladder: 191; bile duct: 5)
Pancreas 54 (3%) 2 (malignant 2) Enlargement: 24
Kidney/ureter 643 (31%) 13 (benign) Cyst: 368; stone: 170
Adrenal gland 22 (10%) 11 (benign) Hypertrophy: 5
Uterus 125 (6%) 3 (benign) Myoma: 100
Ovary 54 (3%) 12 (malignant 1) Cyst: 33
Prostate 93 (4%) 2 (benign) Hypertrophy: 53; calcification: 10
Lung/pleura 29 (1%) 2 (malignant 1) Inflammation: 17
Aorta/iliac artery 66 (3%) Atherosclerosis: 24; aneurysm: 22; calcification: 13
Heart 11 (0.5%) Cardiomegaly/pericardial effusion: 10 (aortic valve 
regurgitation: 1; mitral valve regurgitation: 1)
Others 140 (7%) Spleen: 17; bone: 14; gastrointestinal: 68
*Total number of suspected solid tumours: 56; malignancy confirmed: 5.
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compared to the scanning for the lung field. In this study,
scanning parameters were fixed at 120 kV/150 mA to sim-
plify the procedure, and good diagnostic images were
obtained in all participants. In the mass screening for lung
cancer using mobile CT scanner,9 the scanning parameters
were fixed at 120 kV/50 mA. The scanning parameter for
abdomen may be reduced probably to less than 100 mA
except for very obese patients in the next series. The helical
CT system easily accommodated the scanning of 12 partici-
pants every hour. In this series, CT images were acquired
with 10 mm collimation considering the load on X-ray
system and the total number of slices per patient. In order
to reduce false-negatives, 5 mm interval should be
adopted. It is crucial to reduce the potential harms of
mass screening including false-positive and false-negative
tests. In the next stage, we need to re-evaluate our screen-
ing procedures to improve diagnostic accuracy. It is also
important for candidates to understand the efficacy and
the limitation of the screening test itself. In this screen-
ing procedure, we gave sufficient information to candi-
dates both before and after the screening test to remove
unnecessary anxieties.
In this study, solid tumours were suspected in 56 lesions,
but only five were confirmed to be malignant tumours.
Therefore, qualitative diagnoses of solid tumours were
difficult using CT findings without contrast medium.
Thus, enhanced CT scanning might be included in the
next stage. The prevalence rate of AAA was 0.5%, which
was almost similar to the 0.3% in our previous US screen-
ing.2 The screening cost for AAA was greater with CT screen-
ing than with US screening2 (US$10,325 vs. US$2,335). It
was interesting that lung cancer in the lower lung field and
heart valve diseases were uniquely detected in spite of the
limited field of the abdominal screening. Initial diagnosis
was made by certificated specialists in radiology, and fol-
lowed by physicians who specialized in the field of each
organ for further examination and treatment when neces-
sary. We thought that this kind of two-staged diagnosis pro-
gramme was effective to screen multiple abdominal organs.
However, additional examinations were necessary for final
diagnoses, which increased total medical cost. Abdominal
screening using mobile CT scanner has not been popular.
In the initial stage, we did not use any exclusion criteria
except for age in order to know the prevalence rate of each
abdominal disease. However, the positive yield of malig-
nant lesions was only 0.1%, thus we should limit it to a
high-risk population in the next stage. In conclusion, an
abdominal mass screening procedure using mobile CT
scanner requires further investigation in the aspect of the
selection of examinees, CT scanning procedures, sensitivity
and specificity and cost-effectiveness.
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Table 2. Screening costs in tumour lesions and cardiovascular 
diseases
No. of Prevalence
Cost per
Disease
lesions (%)
diagnosis
(US$)
Tumour
Malignant 5 0.1 45,430
Benign 51 1.1 4,454
Cardiovascular
Aneurysm 22 0.5 10,325
(aorta/iliac artery)
Valve disease 2 0.04 113,575
